Memorial Sloan Kettering Cancer Center

A pioneering research center in immune-based cancer treatments for more than a century

Immunotherapy was born at Memorial Sloan Kettering Cancer Center (MSK) more than a century ago. The center is home to a diverse group of scientists who study the immune system in all its complexity. They are developing groundbreaking immune therapies that are helping to treat several forms of advanced cancer. The Parker Institute members at MSK are dreaming big – pursuing projects that will not only improve existing immunotherapies but also open the door to new ones.

Jedd Wolchok, MD, PhD

Director

Marcel van den Brink, MD, PhD

Co-Director

Research Focuses

Checkpoint Blockade Response

Uncover the reasons why some patients respond to immunotherapy while others may not, in order to overcome cancer drug resistance.

More

Tumor Microenvironment

Discover how tumor masses impair immune cells to jumpstart the creation of therapies to fight back against hard-to-treat solid tumors.

More

For Advanced Pancreatic Cancer, Combining Immunotherapies with Chemotherapy Shows Early Promise in Reducing Tumor Size

March 31, 2019

More Updates

Members

Charlotte Ariyan, MD, PhD

Vinod Balachandran, MD

Margaret Callahan, MD, PhD

Claire Friedman, MD

Matthew D. Hellmann, MD

Travis Hollmann, MD, PhD

Scott James, MD, PhD

Danny Khalil, MD, PhD

Christopher A. Klebanoff, MD

Alexander Lesokhin, MD

Taha Merghoub, PhD

Dana Pe’er, PhD

Alexander Y. Rudensky, PhD

Bianca Santomasso, MD, PhD

Andrea Schietinger, PhD

Santosh Vardhana, MD, PhD

A pioneering research center in immune-based cancer treatments for more than a century

Research Focuses

Checkpoint Blockade Response

Tumor Microenvironment

What’s New

PICI Picks from AACR 2019

PICI Young Investigator Retreat 2019

For Advanced Pancreatic Cancer, Combining Immunotherapies with Chemotherapy Shows Early Promise in Reducing Tumor Size

Members

Charlotte Ariyan, MD, PhD

Vinod Balachandran, MD

Margaret Callahan, MD, PhD

Claire Friedman, MD

Matthew D. Hellmann, MD

Travis Hollmann, MD, PhD

Scott James, MD, PhD

Danny Khalil, MD, PhD

Christopher A. Klebanoff, MD

Alexander Lesokhin, MD

Taha Merghoub, PhD

Dana Pe’er, PhD

Alexander Y. Rudensky, PhD

Bianca Santomasso, MD, PhD

Andrea Schietinger, PhD

Santosh Vardhana, MD, PhD

Phillip Wong, PhD

Dmitriy Zamarin, MD, PhD

Roberta Zappasodi, PhD

Memorial Sloan Kettering Cancer Center

A pioneering research center in immune-based cancer treatments for more than a century

Research Focuses

Checkpoint Blockade Response

Tumor Microenvironment

What’s New

PICI Picks from AACR 2019

PICI Young Investigator Retreat 2019

For Advanced Pancreatic Cancer, Combining Immunotherapies with Chemotherapy Shows Early Promise in Reducing Tumor Size

Members

Charlotte Ariyan, MD, PhD

Vinod Balachandran, MD

Margaret Callahan, MD, PhD

Claire Friedman, MD

Matthew D. Hellmann, MD

Travis Hollmann, MD, PhD

Scott James, MD, PhD

Danny Khalil, MD, PhD

Christopher A. Klebanoff, MD

Alexander Lesokhin, MD

Taha Merghoub, PhD

Dana Pe’er, PhD

Alexander Y. Rudensky, PhD

Bianca Santomasso, MD, PhD

Andrea Schietinger, PhD

Santosh Vardhana, MD, PhD

Phillip Wong, PhD

Dmitriy Zamarin, MD, PhD

Roberta Zappasodi, PhD

Get Email Updates